BS194

Synonyma:: BS194;CS-2655;BS-194;BS 194;BS194, 10 mM in DMSO;(2S,3S)-3-(7-(benzylaMino)-3-isopropylpyrazolo[1,5-a]pyriMidin-5-ylaMino)butane-1,2,4-triol;(2S,3S)-3-{[7-(benzylamino)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-5-yl]amino}butane-1,2,4-triol;(2S,3S)-3-[[3-(1-Methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]-1,2,4-butanetriol;1,2,4-Butanetriol, 3-[[3-(1-Methylethyl)-7-[(phenylMethyl)aMino]pyrazolo[1,5-a]pyriMidin-5-yl]aMino]-, (2S,3S)-;BS-194,Antitumor,breast cancer,BS 194,xenografts,CDK,Inhibitor,MCF-7,colon cancer,retinoblastoma,BS194,anti-cancer,Cyclin dependent kinase,inhibit,HCT-116

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 42

BS194 Eigenschaften

Global( 42)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	33024	60
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32466	58
HANGZHOU CLAP TECHNOLOGY CO.,LTD	86-571-88216897,88216896 13588875226	sales@hzclap.com	CHINA	6312	58
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49734	58
TargetMol Chemicals Inc.	+1-781-999-5354;	support@targetmol.com	United States	39039	58
Aladdin Scientific		tp@aladdinsci.com	United States	52923	58
Amadis Chemical Company Limited	571-89925085	sales@amadischem.com	China	131956	58
SYN\|thesis med chem P/L	+86-021-50720296	service@synkinase.com	China	266	58
Shanghai Lollane Biological Technology Co.,Ltd.	021-52996696，15000506266 15000506266		China	4849	55
Pharmacodia (Beijing) Co.,Ltd	+86-400-851-9921	sales@pharmacodia.com	China	2317	55

BS194
(2S,3S)-3-(7-(benzylaMino)-3-isopropylpyrazolo[1,5-a]pyriMidin-5-ylaMino)butane-1,2,4-triol
1,2,4-Butanetriol, 3-[[3-(1-Methylethyl)-7-[(phenylMethyl)aMino]pyrazolo[1,5-a]pyriMidin-5-yl]aMino]-, (2S,3S)-
(2S,3S)-3-[[3-(1-Methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]-1,2,4-butanetriol
CS-2655
BS-194;BS 194
BS-194,Antitumor,breast cancer,BS 194,xenografts,CDK,Inhibitor,MCF-7,colon cancer,retinoblastoma,BS194,anti-cancer,Cyclin dependent kinase,inhibit,HCT-116
(2S,3S)-3-{[7-(benzylamino)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-5-yl]amino}butane-1,2,4-triol
BS194, 10 mM in DMSO
1092443-55-4